Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
AUTHORS
Lazova
RRossitza ,
Seeley
EH Erin H ,
Kutzner
H Heinz ,
Scolyer
RA Richard A ,
Scott
G Glynis ,
Cerroni
L Lorenzo ,
Fried
I Isabella ,
Kozovska
ME Milena E ,
Rosenberg
AS Arlene S ,
Prieto
VG Victor G ,
Shehata
BM Bahig M ,
Durham
MM Megan M ,
Henry
G Gina ,
Rodriguez-Peralto
JL Jose L ,
Riveiro-Falkenbach
E Erica ,
Schaefer
JT Jochen T ,
Danialan
R Richard ,
Fraitag
S Sylvie ,
Vollenweider-Roten
S Sonja ,
Sepehr
A Alireza ,
Sangueza
M Martin ,
Hijazi
N Nouf ,
Corredoira
Y Yamile ,
Kowal
R Rachel ,
Harris
OM Olga M ,
Bravo
F Francisco ,
Boyd
AS Alan S ,
Gueorguieva
R Ralitza ,
Caprioli
RM Richard M .
Journal of the American Academy of Dermatology. 2016 8 5; ().
ABSTRACT
Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas.
Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas.